Skip to content

Covid-19 + Influenza A/B Combo Rapid Test

by Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd. EUDAMED

Active European Union

Ref CIC-02

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-CIC-025X Basic UDI-DIDate30 Dec 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Certificates

0 certificates · EUDAMED

No notified-body certificate is listed. Devices of this class are self-declared by the manufacturer.

Specification

EUDAMED

Model / Reference
CIC-02
Primary DI / UDI-DI
D-CIC-025X
Basic UDI-DI
B-CIC-025X
EMDN Code
W0105099004 Influenza a and /or b - rt & poc
Device Class
Class IVD General
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
CN-MF-000020377
Authorised representative
MedPath GmbH DE-AR-000000087

Other devices from Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd

See all devices from Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd →

Properties

  • Reagent
  • Near-Patient Testing
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No